Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 56 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Alpha pharma from Roeselare, company number BE0544737350, closed financial year 2025 with a result of € 120,622 after tax. For that financial year Alpha pharma recorded a gross margin of € 352,515 and equity of € 627,122. Compared with financial year 2024, the result moved from € 114,414 to € 120,622. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 627,122
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 120,622
▲ 5% vs 2024
Profit after tax over the fiscal year.
€ 168,312
▼ 4% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 62,500 paid out
52 % of the profit went to the shareholders, mostly to JM (80 % of the shares). That is where the money ends up.
People and assets in 2025
2.2
▲ 0.6 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 137,316
▲ 53% vs 2024
€ 62,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,098
▼ 48% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 226,861
▼ 18% vs 2024
€ 46,301 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 198,424
▲ 30% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 40,269
▲ 71% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 326,494 | € 369,448 | € 308,603 | € 352,515 | ▲ 14% |
| Profit after taxes | € 120,457 | € 138,773 | € 114,414 | € 120,622 | ▲ 5% |
| Equity | € 315,813 | € 454,586 | € 569,000 | € 627,122 | ▲ 10% |
| Total debts | € 931,473 | € 743,711 | € 679,645 | € 827,744 | ▲ 22% |
| Cash | € 131,110 | € 119,238 | € 174,724 | € 168,312 | ▼ 4% |
| Land & buildings | € 760,812 | € 721,446 | € 683,677 | € 885,670 | ▲ 30% |
| Retained profit | € 297,213 | € 435,986 | € 550,400 | € 608,522 | ▲ 11% |
| Dividend | € 377,117 | € 0 | € 0 | € 62,500 | |
| Bank debt | € 411,832 | € 330,158 | € 275,894 | € 226,861 | ▼ 18% |
| Balance sheet total | € 1,247,286 | € 1,198,297 | € 1,248,645 | € 1,454,866 | ▲ 17% |
| Employees (FTE) | 1.1 | 1.9 | 1.6 | 2.2 | ▲ 0.6 |
By gross margin, Alpha pharma ranks 7th of 22 companies with main activity “Detailhandel in farmaceutische producten” in Roeselare that publish figures (fiscal year 2025).
Key figures of Alpha pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Alpha pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Alpha pharma?
What happened at Alpha pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 120,622 (▲ 5% vs 2024). Source: NBB ↗
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 120,457 profit in 2022 to € 120,622 profit in 2025.
Paid € 182,729 in corporate taxes since 2022.
Best year ever: 2023, with € 138,773 profit.
On average € 160,200 of value added per employee in 2025.
Management
The stake of JM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Alpha pharmaBehind Alpha pharma is JM BV. The shares are held by JM (80%).
Establishments
Establishment units
Physical locations of this company
Oekensestraat 140B
8800 Roeselare
Oekensestraat 116
8800 Roeselare
Active since 17 January 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Roeselare
Same main activity (Detailhandel in farmaceutische producten), 24 active companies in Roeselare, largest first.
€ 948,427 gross margin · 2026
€ 916,383 gross margin · 2025
€ 659,622 gross margin · 2025
€ 473,925 gross margin · 2024
€ 416,750 gross margin · 2025
€ 375,798 gross margin · 2025
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0544.737.350
- VAT number
- BE 0544.737.350
- Registered office
- Oekensestraat 140B, 8800 Roeselare
- Names & denominations
- Alpha pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 January 2014
- Peppol
- Active · Active since 3 May 2025
- Contact
- alphapharma.be
- Activities · NACE
Detailhandel in farmaceutische producten